Full Text View
Tabular View
No Study Results Posted
Related Studies
Erlotinib Prevention of Oral Cancer (EPOC)
This study is ongoing, but not recruiting participants.
Study NCT00402779   Information provided by M.D. Anderson Cancer Center

First Received on November 20, 2006.   Last Updated on November 15, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Oral Cancer
Additional conditions recognized in this trial
Lip Neoplasms
Mouth Neoplasms
More general conditions related to this trial
Head and Neck Neoplasms
Lip Diseases
Mouth Diseases
Neoplasms
Neoplasms by Site
Stomatognathic Diseases
Interventions listed in this trial
Erlotinib
Placebo
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Kinase Inhibitors
Sponsors listed in this trial
M.D. Anderson Cancer Center
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services